Opioids Market to Soar to USD 29.5 Billion by 2033 | Driven by Chronic Pain Prevalence and Increasing Surgical Procedures
13 févr. 2024 07h23 HE
|
Market.Us
New York, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Opioids Market size is projected to exceed USD 29.5 Billion by 2033, with a promising CAGR of 2.9% from 2024 to 2033. ...
Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven Pharmaceuticals, Pfizer, Biogen, Tonix Pharmaceuticals, Amzell, Bayer, and Others
07 févr. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven...
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
01 févr. 2024 10h00 HE
|
Silo Pharma, Inc.
Preparing Pre-Investigational New Drug Application for lead drug program SPC-15 Company plans to pursue FDA streamlined 505(b)(2) pathway for clinical drug development SARASOTA, FL, Feb. 01,...
Fibromyalgia Treatment Market Projected to Surpass US$ 2.7 Billion in Revenue by 2033, According to Persistence Market Research
18 janv. 2024 09h45 HE
|
Persistence Market Research
New York, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global revenue from the fibromyalgia treatment market stands at US$ 1.3 billion in 2022, with the global market expected to grow...
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
18 janv. 2024 08h00 HE
|
Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
Patient-controlled Analgesic Pumps Market Poised to Hit Striking US$ 712 Million Valuation by 2033 | Persistence Market Research
11 janv. 2024 07h00 HE
|
Persistence Market Research
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Patient-controlled Analgesic Pumps Market is a segment within the broader medical device industry, primarily focused on providing...
Digital Biomarkers Market revenue to hit USD 83.8 Billion by 2035, says Research Nester
05 déc. 2023 06h00 HE
|
Research Nester
New York , Dec. 05, 2023 (GLOBE NEWSWIRE) -- The global digital biomarkers market size is expected to expand at 32.15% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD...
Curonix Celebrates 1st Anniversary
01 nov. 2023 09h00 HE
|
Curonix LLC
POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...
Neuromodulation Market is Projected to Gain $4,342.50 Million by 2030, Claims Allied Market Research
31 oct. 2023 09h30 HE
|
Allied Market Research
Wilmington, Delaware, Oct. 31, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global neuromodulation market to generate $4,342.50 million by 2030,...
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)
27 sept. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of two peer...